| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. Peltola, Palmio, and Keränen) and Pediatrics (Dr. Knip), Tampere University Hospital, Finland; the Departments of Neurology (Drs. Isojärvi and Latvala) and Pediatrics (Drs. Kulmala and Savola), Oulu University Hospital, Finland; and the Service of Neurology (Drs. Saiz and Graus), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Spain.
Address correspondence and reprint requests to Dr. Jukka Peltola, Medical School, University of Tampere, FIN-33014 Finland; e-mail: lljupe{at}uta.fi
BACKGROUND: Autoantibodies to glutamic acid decarboxylase (GAD-A) are present in type 1 diabetes and stiff man syndrome (SMS), and have also been reported in cerebellar ataxia. Epilepsy was present in 4 of 19 patients with SMS and GAD-A, implying that epilepsy sometimes is associated with anti-GAD autoimmunity.
METHODS: The authors investigated the prevalence of GAD-A in patients with therapy-resistant localization-related epilepsy (n = 51) and generalized epilepsy (n = 49) by a radiobinding assay. The positive samples were confirmed by immunohistochemistry and immunoblotting of recombinant human GAD65.
RESULTS: GAD-A were found in eight patients with localization-related epilepsy, whereas none of the patients with generalized epilepsy, other neurologic disorders (n = 38), or the control subjects (n = 48) had GAD-A. Two patients had high levels of GAD-A, similar to SMS, whereas six patients had significantly lower titers, characteristic of type 1 diabetes. The two patients with high levels of GAD-A had GAD-A both in serum and CSF by immunohistochemistry and immunoblotting. Both of them had longstanding therapy-resistant temporal lobe epilepsy but did not have diabetes. One had a history of autoimmune disease, whereas the other had serologic evidence of multiple autoantibodies without any clinical signs of autoimmune disease.
CONCLUSIONS: GAD autoimmunity may be associated with refractory localization-related epilepsy.
This article has been cited by other articles:
|
|
 |
|
  S Vulliemoz, G Vanini, A Truffert, C Chizzolini, and M Seeck Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies J. Neurol. Neurosurg. Psychiatry, February 1, 2007; 78(2): 187 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Cimaz, P L Meroni, and Y Shoenfeld Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome) Lupus, April 1, 2006; 15(4): 191 - 197. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Vernino Neurologic autoantibodies: Cautious enthusiasm Neurology, December 13, 2005; 65(11): 1688 - 1689. [Full Text] [PDF]
|
|
|
|
|
|
K. McKnight, Y. Jiang, Y. Hart, A. Cavey, S. Wroe, M. Blank, Y. Shoenfeld, A. Vincent, J. Palace, and B. Lang Serum antibodies in epilepsy and seizure-associated disorders Neurology, December 13, 2005; 65(11): 1730 - 1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Raju, J. Foote, J. P. Banga, T. R. Hall, C. J. Padoa, M. C. Dalakas, E. Ortqvist, and C. S. Hampe Analysis of GAD65 Autoantibodies in Stiff-Person Syndrome Patients J. Immunol., December 1, 2005; 175(11): 7755 - 7762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vernino and V. A. Lennon Autoantibody Profiles and Neurological Correlations of Thymoma Clin. Cancer Res., November 1, 2004; 10(21): 7270 - 7275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lerman-Sagie, N. Watemberg, C. Vinkler, J. Fishhof, E. Leshinsky-Silver, and D. Lev Familial Hyperekplexia and Refractory Status Epilepticus: A New Autosomal Recessive Syndrome J Child Neurol, July 1, 2004; 19(7): 522 - 525. [Abstract] [PDF]
|
|
|
|
|
|
C. Koerner, B. Wieland, W. Richter, and H.-M. Meinck Stiff-person syndromes: Motor cortex hyperexcitability correlates with anti-GAD autoimmunity Neurology, April 27, 2004; 62(8): 1357 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Sokol, J. A. McIntyre, D. R. Wagenknecht, E. J. Dropcho, H. Patel, V. Salanova, and G. da Costa Antiphospholipid and glutamic acid decarboxylase antibodies in patients with focal epilepsy Neurology, February 10, 2004; 62(3): 517 - 518. [Full Text] [PDF]
|
|
|
|
|
|
G Antonini, R Nemni, F Giubilei, F Gragnani, V Ceschin, S Morino, E Bucci, and N Accornero Autoantibodies to glutamic acid decarboxylase in downbeat nystagmus J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 998 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Dalakas, M. Li, M. Fujii, and D. M. Jacobowitz Stiff person syndrome: Quantification, specificity, and intrathecal synthesis of GAD65 antibodies Neurology, September 11, 2001; 57(5): 780 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H-M Meinck, L Faber, N Morgenthaler, J Seissler, S Maile, M Butler, M Solimena, P DeCamilli, and W. Scherbaum Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases J. Neurol. Neurosurg. Psychiatry, July 1, 2001; 71(1): 100 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. A.C. Petroff, F. Hyder, D. L. Rothman, and R. H. Mattson Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures Neurology, March 27, 2001; 56(6): 709 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.C. Marchiori, A. Vaglia, M. Vianello, P.G. Bardin, and B. Giometto Encephalitis associated with glutamic acid decarboxylase autoantibodies Neurology, March 27, 2001; 56(6): 814 - 814. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
